A New Book from the Wall Street Journal and USA Today Bestselling Author
The Most Valuable Companies in the World Leverage a Powerful Secret. Do you?
Taylor Swift isn’t a singer, songwriter, or entertainer. She’s an IP Company-filing over 300 trademarks (and counting), including The Tortured Poets Department, Swiftites, Tayplay, and even her cat’s names-Meredith and Olivia Swift. Taylor Swift doesn’t protect her IP because she’s a big star. She’s a big star because she protects her IP.
Play-Doh also takes its IP seriously, protecting the scent of its modeling compound with the proprietary description, ‘Sweet, slightly musky, vanilla fragrance, with slight overtones of cherry, combined with the smell of a salted, wheat-based dough.’ Even The Coca-Cola Company knows its value is found in its trade secret, not the carbonated beverage it bottles.
You’re not that different. But sadly, most entrepreneurs don’t think they have any intellectual property. Truth is, they just don’t know how to find it. The few who do, don’t know how to protect it. Over 90% of your company’s value is linked to your IP. Unless you value your IP, your clients, competitors, and collaborators won’t truly value you.
Kary Oberbrunner, entrepreneur and inventor of Instant IP™, and Katherine Rubino, a Partner at Caldwell, the fastest-growing IP law firm in America for more than four years in a row, team up to offer a proven guide for identifying your ideas and protecting them the fastest, easiest, and most effective way possible.
Get ready to discover:
- Why you should not promote your IP until you first protect your IP
- Which IP protection strategy makes sense for your unique circumstances
Your Ideas are Valuable. Start Protecting Them Today.
关于作者
Katie is a partner and director of Caldwell’s life science practice group. Katie focuses on the representation of life sciences companies discovering, developing, protecting and offering pharmaceuticals, therapeutic vaccines, digital health, medical devices, biologics, and antibody products.Katie has been featured in the Wall Street Journal, Fox Business, and Nature Biotechnology for her intellectual prowess governing legal and scientific disputes. Katie specializes in transactions involving intellectual property rights, strategic partnerships, licensing, and research collaborations. In addition, she maintains an active practice in cross-border transactions, being dually qualified to practice in both the United States and England and Wales.Katie is the past-chair of the Chemistry and the Law division of the American Chemical Society. She is a fixture of the entrepreneurial ecosystem and provides pro-bono legal advice in partnership with MIT Sandbox and Oregon Bioscience Incubator.